Neuronal activity is communicated to the cerebral vasculature so that adequate perfusion of brain tissue is maintained at all levels of neuronal metabolism. An increase in neuronal activity is accompanied by vasodilation and an increase in local cerebral blood flow. This process, known as neurovascular coupling (NVC) or functional hyperemia, is essential for cerebral homeostasis and survival. Neuronal activity is encoded in astrocytic Ca 2+ signals that travel to astrocytic processes ('endfeet') encasing parenchymal arterioles within the brain. Astrocytic Ca 2+ signals cause the release of vasoactive substances to cause relaxation, and in some circumstances contraction, of the smooth muscle cells (SMCs) of parenchymal arterioles to modulate local cerebral blood flow. Activation of potassium channels in the SMCs has been proposed to mediate NVC. Here, the current state of knowledge of NVC and potassium channels in parenchymal arterioles is reviewed. (Circ J 2010; 74: 608 - 616) 
aintenance of cerebral homeostasis requires dynamic regulation of oxygen and glucose supply so as to match nutrient delivery to metabolic demand. 1 This is achieved through extensive and precise regulation of blood flow within the brain. In the normally functioning brain, increases in neuronal activity are accompanied by rapid, spatially localized increases in blood flow that serve to avoid the development of ischemic conditions in active regions of the brain. [2] [3] [4] [5] [6] This coupling of increased neuronal activity to increased local cerebral blood flow (CBF), a process known as functional hyperemia or neurovascular coupling (NVC), occurs as a result of vasodilation at the level of the cerebral microcirculation and appears to depend on the generation of vasoactive substances. 1 Abnormalities associated with cerebral microcirculatory function have been associated with a number of disorders, including Parkinson's disease, stroke, and migraine. 7 In addition, chronically insufficient CBF is an end result of most risk factors associated with neurodegenerative diseases such as Alzheimer's disease and early onset dementia. 8 Thus, elucidating the mechanisms by which neuronal activity regulates intracerebral arterioles is critical to the development of new targets and effective therapies for pathological conditions associated with cerebral microcirculatory dysfunction. Potassium (K + ) channels play a central role in NVC and represent one such target for future therapeutics. The purpose of this review is to examine putative mechanisms of NVC and the role of K + channels in this process.
Blood flow to the brain is first conducted through a series of pial arteries on the surface of the brain, then through intracerebral arteries and arterioles within the brain tissue. Intracerebral (parenchymal) arterioles arise from branches of pial arteries that penetrate from the surface of the brain into the parenchyma ( Figure 1 ). 9 Parenchymal arterioles are structurally and functionally distinct from pial arteries. Within the cerebral cortex, these arterioles begin immediately distal to the Virchow-Robin space, are encased in astrocytic processes called 'endfeet', and terminate as an extensive capillary network. Parenchymal arterioles lack the extrinsic innervation of larger pial arteries, with primary regulation arising from astrocytes and neurons of central origin. 2,10, 11 Recent evidence suggests that astrocytes play a significant role in the regulation of local CBF. 2,7,12- 15 An individual astrocyte has numerous processes that surround multiple synapses, and thus forms a tripartite synapse with pre-and post-synaptic neurons. 16 Astrocytes also possess additional processes that target the cerebral microcirculation. These astrocytic processes terminate as perivascular endfeet that encase smooth muscle cells (SMCs) of parenchymal arterioles and capillaries ( Figure 1 ). 2,12-15, 17 This astrocytic architecture suggests that an individual astrocyte might be capable of integrating the activity of multiple neurons and translating this information into physiological signals, including those that regulate CBF by altering the vascular tone of parenchymal arterioles. Indeed, recent evidence points to a central role for astrocytes in functional hyperemia in the brain. Neurons themselves also release a number of important vasoactive substances, including nitric oxide, adenosine, and neurotransmitters; however, the potential role of these neuronal mediators in NVC is beyond the scope of the current review. 7, 18 Astrocytes act as vital regulators of neuronal function, serving to modulate extracellular potassium (K + ) concentration ([K + ]o) and extracellular volume, and remove neurotransmitters from synapses. 19-21 Astrocytes possess numerous receptors that could be activated by neurotransmitters.
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Potassium Channels and Neurovascular Coupling
Activation of metabotropic glutamate receptors (mGluRs) located on astrocytic projections that surround synapses of glutamatergic neurons results in an increase in cytosolic calcium concentration ([Ca 2+ ]c) in the soma, which then propagates through astrocytic processes, ultimately resulting in a [Ca 2+ ]c increase in the endfoot (Figure 2) . 25,26 These [Ca 2+ ]c increases likely occur through activation of the phospholipase C/inositol trisphosphate (InsP3) cascade, and involve release of endoplasmic reticulum Ca 2+ through InsP3 receptors and possibly ryanodine receptors. 26, 27 Zonta et al elegantly showed that the dilation of cortical arterioles is dependent on astrocytic [Ca 2+ ]c increases induced by glutamate activation of mGluRs. 14 Thus, the release of vasoactive substances from astrocytes in response to neuronal activation requires elevation of endfoot [Ca 2+ ], although the mechanisms underlying the generation of these signals and the nature of these mediators are poorly understood. 12-14
Astrocytic Signals and NVC
Several signals based on arachidonic acid (AA) metabolism have been proposed to modulate vessel diameter in response to neuronal activity ( Figure 2) . 12,14,28, 29 Glutamate activation of astrocytic mGluRs leads to the Ca 2+ -dependent stimulation of phospholiase A2 (PLA2) and production of AA, which is metabolized to epoxyeicosatrienoic acid (EETs) by the action of cytochrome P450 (CYP) epoxygenases, with 11,12-EET and 14,15-EET being major vasoactive components. 2+ ] stimulates PLA2, which produces AA that then diffuses to the parenchymal arteriolar SMCs, where it is converted to 20-HETE by CYP ω-hydroxylase. 12 The suggestion is that 20-HETE constricts arterioles by inhibiting SMC large-conductance calcium-sensitive K + (BK) channels, Figure 1 . Pial arteries on the surface of the brain penetrate into the cortical parenchyma to give rise to parenchymal arterioles. Pial arteries are extrinsically innervated by sympathetic nerves (shown in white). As the arteriole penetrates into the brain parenchyma beyond the Virchow-Robin space, extrinsic innervation is lost and the arteriole becomes completely encased in astrocytic terminal processes called 'endfeet'. Astrocytes integrate information from neurons and other cell types (ie, interneurons) and translate that information into dynamic astrocytic Ca 2+ signals that propagate to the endfoot and regulate parenchymal arteriolar tone in order to regulate local cerebral blood flow according to the metabolic needs of the surrounding tissue.
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an inference based on the inhibitory effects of the PLA2 inhibitor MAFP (100 μmol/L) and the 20-HETE synthesisinhibitor HET0016 (100 μmol/L) on the observed constriction. However, these experiments examined non-preconstricted arterioles in brain slices, and the contribution of BK channels is expected to be negligible in the absence of tone. 37 Accordingly, it is difficult to reconcile the observed constrictor effect of 20-HETE with a mechanism involving inhibition of vascular SMC BK channels. In addition, these observations must be interpreted with caution as the concentration of HET0016 used was very high (100 μmol/L), and likely to non-selectively inhibit the formation of other AA metabolites that might be involved in NVC. In human renal microsomes, the IC50 of HET0016 on CYP epoxygenase and COX activities is 2.8 μmol/L and 2.3 μmol/L, respectively. 38 Also, 1 μmol/L HET0016 is sufficient to block 20-HETE production in intact cerebral arteries by 90%. 39 Thus, the actual role of 20-HETE in NVC and its direct functional effects on parenchymal arterioles remains uncertain.
One astrocytic signal that clearly has the potential to generate both vasodilation and vasoconstriction is K + . 40 The regulation of [K + ]o by astrocytes has been extensively studied in the retina, where astrocytes are suggested to function as a K + siphon, taking up K + from regions of high concentration (perisynaptic regions) and releasing K + to regions of lower extracellular concentration (perivascular regions). 21 Consistent with this K + buffering role, astrocytes display a large K + conductance; a hyperpolarized Vm (approximately -80 mV) that is positive to the K + equilibrium potential, EK (-102 mV); and exhibit polarized expression of K + channels. 41, 42 Specifically, BK channels are abundantly expressed in perivascular endfeet. 43 In brain slices, neuronal stimulation by EFS pro- ] also activates the Ca 2+ sensitive enzyme cytosolic phoshpolipase A2 (PLA2). PLA2 hydrolyzes membrane phospholipids to release the fatty acid arachidonic acid (AA). AA is then metabolized by cyclooxygenase (COX) and prostaglandin synthases to yield PGE2, or is believed to diffuse to the parenchymal arteriole SMC, where it is metabolized by cytochrome P-450 enzymes to generate EETs and/or 20-HETE. The mechanism of action of PGE2 on parenchymal arteriole SMCs is unknown, but based on studies done in pial arteries, it might involve cAMP-dependent activation of SMC BK channels, and subsequent SMC hyperpolarization and vasodilation. EETs formed in arteriolar SMCs by the metabolism of astrocytederived AA are proposed to activate SMC BK channels to elicit membrane hyperpolarization and vasodilation. Conversely, 20-HETE is believed to inhibit parenchymal arteriolar SMC BK channels resulting in membrane depolarization, activation of VDCCs, elevation of [Ca 2+ ]i, and vasoconstriction.
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duces Ca 2+ -sensitive K + (BK channel) currents in astrocytic endfeet that are activated by the rise in endfoot [Ca 2+ ] and result in vasodilation. 44 Activation of endfoot BK channels releases K + into the perivascular space, producing a localized elevation in [K + ]o in the spatially restricted microenvironment between the endfoot and the arteriole that is sensed by the arteriolar smooth muscle. By altering the [K + ]o in the perivascular space through endfoot BK channel-mediated K + release, the astrocyte can generate a signal that is capable of producing vasodilation or vasoconstriction. Strong evidence indicates that the vasodilatory response to K + released from the endfoot is mediated by inward-rectifier K + (Kir) channels in parenchymal arteriole smooth muscle. Barium, a selective inhibitor of Kir channels (at concentrations <100 μmol/L), blocks vasodilation elicited by neuronal stimulation with EFS in brain slices, but does not affect the increase in [Ca 2+ ]c in astrocytic endfeet. 44 
K + Channels in the Control of Parenchymal Arteriolar Tone
The membrane potential of arterial SMCs is a key determinant of vascular tone and is regulated by K + channels. Opening of K + channels in vascular SMC membranes allows K + to flow out of the cell, resulting in membrane hyperpolarization, whereas inhibition of K + channels results in membrane depolarization. K + channel-mediated membrane hyperpolarization closes voltage-dependent Ca 2+ channels (VDCCs), which decreases Ca 2+ entry and leads to vasodilation. 45, 46 VDCCs are very sensitive to membrane potential, such that modest fluctuations in membrane potential can dramatically change Ca 2+ entry. 47 Consequently, minor changes in membrane potential can have a significant effect on arterial diameter. 48 The membrane potential of SMCs in parenchymal arterioles pressurized to physiological levels (40 mmHg) is approximately -45 mV, and the arterioles are about 30% constricted. 44 In cerebrospinal fluid, EK is about -102 mV. Membrane potential hyperpolarization to -60 mV causes a maximum dilation of cerebral arteries, and depolarization to approximately -30 mV causes maximal constriction. 48 Therefore, even modest activation of SMC K + channels can cause significant vasodilation.
The 4 different subtypes of K + channels identified in arterial SMCs are inward rectifier K + (Kir) channels, Ca 2+ -sensitive K + (KCa) channels, voltage-dependent K + (Kv) channels, and ATP-sensitive K + (KATP) channels. 49 The expression profile and functional contribution of each subtype can vary according to tissue bed and caliber of the arterial segment. 50 There is functional evidence for all 4 K + channel subtypes in SMCs of parenchymal arterioles, but their relative roles have not been as well characterized as in pial artery SMCs.
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Kir Channels A number of arteries, including cerebral and coronary arteries, dilate to a modest elevation in extracellular K + . K + -induced dilations are caused by activation of strong inward rectifier K + channels in the SMCs. 49 In pial arteries, disruption of the gene for the strong inward rectifier K + channel, Kir2.1, abolished K + -induced dilations. 55, 56 The property of inward rectification is likely conferred to Kir channels through the drawing out of positively charged polyamines plugging the inside of the pore by membrane potential hyperpolarization. 57- 59 The midpoint-of the-activation curve for Kir channels corresponds to EK, such that elevation of external K + shifts the activation curve to more positive potentials. 60 The 
BK Channels
BK channels have been identified in virtually every type of smooth muscle. The characteristic smooth muscle BK channel complex is composed of an α pore-forming subunit and an auxillary β1 subunit. 63- 65 The β1 subunit acts to increase the apparent voltage-and Ca 2+ -sensitivity of the channel. Targeted disruption of the β1 subunit gene leads to hypertension and left ventricular hypertrophy. 66 A number of recent animal studies have shown that the β1 subunit, and hence BK channel function, is downregulated in hypertension and diabetes. 67-71 Two polymorphisms of the BK channel β1 subunit -KCNMB1-E65K and KCNMB1-V110L -are common in multiple ethnic and racial groups; an additional polymorphism (R140 W) is found in individuals of African descent. The first non-synonymous coding polymorphism was described by Fernandez-Fernandez et al, who identified the E65K polymorphism by direct sequence analysis of the 4 Kcnmb1 exons in a Spanish cohort. 72 Heterologous expression studies in HEK293 cells established that the E65K polymorphism was a gain-of-function variant that increased BK-channel sensitivity to activation by Ca 2+ . Genetic association studies in the Spanish cohort demonstrated that carriers of E65K, which was present in 21% of the population examined, were less likely to have diastolic hypertension. 72 In follow-up studies, the association of E65K with blood pressure appeared to be strongest among post-menopausal women. 73 BK channels are selectively blocked by the scorpion toxins iberiotoxin and charybdotoxin, as well as the alkaloid paxilline. [74] [75] [76] There are a number of synthetic openers of BK channels. 77-79 However, the majority of these openers lack selectivity in intact tissues, and therefore their usefulness has been limited. An exception is NS11021, which has recently been shown to decrease smooth muscle excitability through activation of BK channels. 80 BK channels are directly and DUNN KM et al.
indirectly activated by vasodilators that elevate cGMP and cAMP concentration. 49,81,82 BK channels have also been shown to be modulated by AA metabolites. BK channel activity is inhibited by 20-HETE through protein kinase C (PKC) activation and increased by EETs. 83- 87 BK currents have been identified in parenchymal arteriolar SMCs; however, these currents have been suggested to be quite small in the physiologically relevant voltage range of -50 to -10 mV. 88 In addition, whereas treatment of pressurized pial arteries with BK channel inhibitors causes pronounced vasoconstriction, parenchymal arteriolar tone does not appear to be substantially affected by BK channel inhibition, as BK channel block by subdural superfusion of paxilline (1 μmol/L) does not significantly affect resting cortical CBF in vivo. 51 These observations suggest that, unlike pial arteries, where BK channels appear to play a major role in regulating tone, the functional significance of BK channel activity in parenchymal arterioles might not be substantial. 37 Reduced BK channel-mediated opposition of myogenic tone could potentially explain the greater relative tone observed in parenchymal arterioles compared to pial arteries. 89 The mechanism and physiological significance of diminished basal BK channel activity in pressurized parenchymal arterioles compared to pial arteries is unclear. However, BK channels in parenchymal arteriolar SMCs are involved in modulating vascular diameter in response to vasoactive chemical stimuli. For example, parenchymal arteriolar dilation to glutamate in newborn piglets is mediated by activation of SMC BK channels. 90
Voltage-Dependent Potassium (KV) Channels
KV channels are present in all types of vascular smooth muscle, and serve to oppose depolarizing, contractile influences by virtue of their voltage-dependence. 49 In vascular smooth muscle, the consensus is that these channels are composed of heteromers of KV1.2/1.5. 91,92 KV channels can be inhibited by vasoconstrictors through PKC activation. 93-95 Recent evidence indicates modest elevations of glucose can also inhibit KV channels through activation of PKC. 53, 96 The 4-aminopyridine (4-AP) is a potent inhibitor of these channels. 62 Selective openers of these channels have not been identified. As in pial arteries, KV channels play a significant role in determining the level of myogenic tone in pressurized parenchymal arterioles. KV channel currents activated by membrane depolarization are observed in parenchymal arteriolar SMCs. 53 The biophysical properties of these currents along with reverse transcription-polymerase chain reaction results indicate that KV channels in parenchymal arterioles are heterotetrameric channels composed of KV1.2 and KV1.5 subtypes. This is the same type of KV channel assembly present in pial artery SMCs. KV current in isolated parenchymal arteriolar SMCs is significantly reduced by application of 4-AP, which also constricts pressurized arterioles and arterioles in brain slices by roughly 40%. Hence, at physiological intravascular pressures KV channels actively oppose myogenic constriction in parenchymal arterioles. There is some evidence that KV channels also mediate changes in membrane potential and vascular tone in parenchymal arterioles in response to vasoactive agents, although this has not been well studied. However, elevated extracellular glucose concentration diminishes KV current in arteriolar SMCs and promotes vasoconstriction of parenchymal arterioles through activation of PKC. 53 KATP Channels KATP channels have been identified in a wide variety of smooth muscle types, and are likely an octomer of 4 sulfonylurea receptors (SUR2B) and 4 inward rectifier (Kir6.1) subunits. 60,97 KATP channels lack voltage-dependence, and exhibit very weak inward rectification. They are also inhibited by intracellular ATP, and may open when ATP/ADP ratio changes during hypoxic or ischemic conditions. 60 Under physiological conditions, SMC KATP channels are potently activated by vasodilators that activate cAMP-dependent protein kinase and are inhibited by vasoconstrictors that activate PKC. 49,60 KATP channels in vascular smooth muscle are potently inhibited by sulfonylurea and hypoglycemic drugs, such as glibenclamide, and are selectively activated by a wide variety of synthetic compounds, such as pinacidil and cromakalim. 60, 98 There is no direct electrophysiological evidence for KATP channels in SMCs of parenchymal arterioles. However, preconstricted parenchymal arterioles dilate in response to levcromakalim, a KATP channel agonist. 54 Additionally, dilation of parenchymal arterioles to mild hypercapnia is blocked by glibenclamide (5 μmol/L), a selective inhibitor of KATP channels. 99 It has also been reported that KATP channel activation mediates parenchymal arteriolar membrane hyperpolarization in response to basic fibroblast growth factor. 100 Glibenclamide-sensitive KATP currents measured in pial artery SMCs are activated by synthetic vasodilators such as pinacidil, as well as by endogenous vasodilators such as calcitonin gene-related peptide and VIP. 101, 102 While there is evidence that supports the presence of KATP channels in parenchymal arteriolar SMCs, the biophysical properties of KATP channels in these vessels are not known, and the functional role of KATP channels in regulating parenchymal arteriolar tone requires further characterization.
Parenchymal Arteriolar Smooth Muscle K + Channels and NVC
Multiple parallel pathways are activated by the increase in [Ca 2+ ]c in astrocytes in response to neuronal activation. This is evidenced by the fact that pharmacological inhibition or genetic manipulation of any of the putative mediators of NVC never fully blocks the vascular response. Also, a rise in astrocytic endfoot [Ca 2+ ]c potentially activates a wide range of Ca 2+ -sensitive proteins. These Ca 2+ -sensitive proteins include BK channels, which release K + ions as a vasoactive signal, as well as PLA2, which provides the substrate (AA) for the generation of eicosanoid and prostanoid vasoactive mediators. Because functional hyperemia in the brain is a prerequisite for survival, it is not surprising that redundant mechanisms have evolved to maintain it. However, redundant parallel mechanisms that ensure functional NVC might ultimately converge on parenchymal arteriolar SMC K + channels to elicit their vascular response.
Vasodilation in Response to Neuronal Activity
Activation of parenchymal arteriolar smooth muscle K + channels during NVC would cause vasodilation and thereby increase local CBF. Here, we consider evidence that putative astrocytic mediators of NVC -external K + , PGE2, and EETsdilate parenchymal arterioles through activation of smooth muscle K + channels.
External K +
As noted above, isolated SMCs from parenchymal arterioles 
PGE2
Based on the effects of COX inhibitors, several groups have proposed that PGE2 released from astrocytic processes is responsible for NVC. 14,103-105 PGE2 (20 μmol/L) has been shown to dilate arterioles in brain slices from neonatal rats. 14 PGE2 might act through EP2 or EP4 prostanoid receptors in SMCs to elevate cAMP, which could lead to vasodilation by activating BK channels or KATP channels. This type of K + channel-dependent mechanism of PGE2 dilation has been documented in renal arteries but has not been explored in parenchymal arterioles. 106 PGE2 dilates pial arteries from cat and rat, and reportedly dilates human middle cerebral arteries through EP4 receptor activation. 107, 108 However, there is limited direct evidence of PGE2-mediated dilation in parenchymal arterioles. COX inhibition with indomethacin dilates pressurized parenchymal arterioles by 15%, but the mechanism of this effect is not known. 109 We have observed that in pressurized mesenteric arteries, PGE2 only dilates the vessel in the presence of functional nitric oxide synthase, suggesting an endothelial effect rather than a SMC effect (unpublished observations). PGE2 has also been reported to elicit vasoconstriction in a variety of arterial segments, including cerebral arteries. 110-112 The direct effect of PGE2 on parenchymal arteriolar tone and its mechanism of action requires further investigation.
EETs
The release of EETs has been proposed to be involved in NVC. 113-116 Subdural superfusion of epoxygenase inhibitors reportedly reduces functional hyperemia in the rat somatosensory cortex by 28-69%. 115 EETs hyperpolarize cerebral artery SM membrane potential and potently dilate pial arteries through direct activation of SM BK channels and through indirect activation of SM BK channels by increasing Ca 2+ sparks. 33,117-121 EET-mediated functional hyperemia in the brain very likely occurs through activation of K + channels in parenchymal arteriolar SMCs. However, the direct effect of EETs on K + channel activity, SMC membrane potential, and parenchymal arteriolar tone has not been investigated.
Vasoconstriction in Response to Neuronal Activity
Several groups have observed vasoconstriction of parenchymal arterioles in response to neuronal activation or Ca 2+ uncaging in astrocytic endfeet. 12,51, 113 The function of vasoconstriction in NVC is unknown, and this phenomenon might be more pathological than physiological. Inhibition of parenchymal arteriolar smooth muscle K + channels would depolarize the membrane and cause vasoconstriction, and there is evidence that the primary putative vasoconstrictor mediator of NVC, 20-HETE, acts through this mechanism. As discussed above, inhibition of 20-HETE formation prevents vasoconstriction of parenchymal arterioles in response to neuronal stimulation in brain slices. 12 The 20-HETE inhibition also prevents light-evoked vasoconstrictions in mammalian retina. 113 This evidence suggests that 20-HETE constricts parenchymal arteriolar SMCs. Direct evidence in parenchymal arterioles is lacking, but 20-HETE potently constricts pial arteries. 122-124 The 20-HETE constricts arteries by inhibiting SMC BK channels through PKC. 84, 85 The physiological significance of this mechanism is unclear, not only because of the questionable function of neuronal activity-induced vasoconstriction, but also because basal BK channel activity in parenchymal arteriole SMCs might be quite low. BK channel blockers have little effect on the diameter of arterioles in brain slices and on resting cortical CBF. 51 External K + can produce parenchymal arteriolar constriction in addition to dilation. 51 In NVC, the astrocyte can tune the polarity of the arteriolar diameter response by altering the magnitude of K + release from the endfoot.
PGE2 also has the potential to mediate neuronal activityinduced constriction. Human pial artery dilation in response to PGE2 occurs through EP4 receptors. 108 In some types of cerebral arteries, PGE2 has been shown to cause constricton through EP1 or EP3 receptors. 112 The specificity of the cerebral vascular response to PGE2 (dilation vs constriction) appears to be conferred by the prostanoid receptors stimulated. Which prostanoid receptor subtypes are expressed and their relative expression in SMCs of parenchymal arterioles is not known. Also, as stated above, the direct effect of PGE2 on parenchymal arterioles has not been studied.
In studies observing vasoconstriction with a rise in astrocytic endfoot Ca 2+ or neuronal activation, a 20-HETE inhibitor, albeit at a high concentration, largely abolished the constrictor response. However, if there is a role for astrocytemediated vasoconstriction in normal physiology or in pathology, external K + , PGE2, and 20-HETE could potentially be mediators.
Indirect Role of Parenchymal Arteriolar SMC K + Channels in NVC
Smooth muscle K + channels also indirectly influence NVC by setting the resting level of tone in parenchymal arterioles prior to neuronal activation. In pial arterioles, the pre-existing level of tone in the vessel determines the magnitude and polarity (constriction vs vasodilation) of the vascular response to vasoactive substances. 126, 127 Similarly, the response of parenchymal arterioles to putative signals involved in NVC is dictated by the resting tone of the vessel. (70-100% of baseline) and dilation in arterioles with greater initial tone. The switch in polarity of vascular response appears to occur at a level of tone corresponding to approximately 50-70% of baseline diameter. As key regulators of membrane potential, and therefore Ca 2+ influx through VDCCs, SMC K + channels are primary determinants of parenchymal arteriolar tone. Therefore, arteriolar SMC K + channels likely play a role in determining the magnitude and polarity of the vascular response to neuronal activation by setting the initial level of tone of the arteriole.
Concluding Remarks
Precise regulation of CBF is essential for homeostasis in the brain. Smooth muscle K + channels are critical regulators of vascular tone and blood flow in cerebral arteries and arterioles. Many mechanisms of chemical, mechanical, and humoral regulation of CBF involve modulation of SMC K + channel activity. Parenchymal arteriolar SMC K + channels are important in the process of NVC and functional hyperemia in the brain, and have potential as therapeutic targets in pathological conditions in which NVC is compromised, including Alzheimer's disease, dementia, diabetes, and hypertension.
